catechin and silybin
catechin has been researched along with silybin in 13 studies
Research
Studies (13)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Kalra, S; Khatik, GL; Kumar, GN; Kumar, R; Narang, R; Nayak, SK; Singh, SK; Sudhakar, K | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Albiñana, CB; Brynda, J; Fanfrlík, J; Flieger, M; Hodek, J; Karlukova, E; Konvalinka, J; Kožíšek, M; Machara, A; Majer, P; Radilová, K; Weber, J; Zima, V | 1 |
| Bijak, M; Krotkiewski, H; Nowak, P; Pawlaczyk, I; Ponczek, M; Saluk, J; Wachowicz, B; Ziewiecki, R | 1 |
| Gardner, TR; Grieco, M; Herath, SA; Jang, JH; Kirchoff, D; Naffouje, S; Njoh, L; Shantha Kumara, HM; Whelan, RL; Yan, X | 1 |
| Blagg, BS; Forsberg, LK; Hall, JA | 1 |
| Khan, H; Murad, S; Neyts, J; Paeshuyse, J | 1 |
| Becerikli, M; Behr, B; Daigeler, A; Harati, A; Harati, K; Hirsch, T; Jacobsen, F; Lehnhardt, M; Renner, M; Wallner, C | 1 |
| Hegde, AR; Kokil, G; Manikkath, J; Mutalik, S; Parekh, HS; Raut, SY; Shetty, PK; Tupally, K | 1 |
| Jin, L; Liang, G; Lv, Y; Wang, Y | 1 |
| Luca, A; Paduraru, L; Stanciu, GD; Stefanescu, R; Tamba, BI | 1 |
| Dasgupta, N; Haque, S; Hussain, A; Mishra, BN; Singh, V; Srivastava, R; Tripathi, S; Unni, S | 1 |
Reviews
2 review(s) available for catechin and silybin
| Article | Year |
|---|---|
Recent advancements in mechanistic studies and structure activity relationship of F
Topics: Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Proton-Translocating ATPases; Structure-Activity Relationship | 2019 |
Secondary Metabolites from Plants Possessing Inhibitory Properties against Beta-Amyloid Aggregation as Revealed by Thioflavin-T Assay and Correlations with Investigations on Transgenic Mouse Models of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzothiazoles; Biological Products; Catechin; Flavonoids; Fluorescent Dyes; Luteolin; Mice; Mice, Transgenic; Protein Aggregates; Silybin | 2020 |
Other Studies
11 other study(ies) available for catechin and silybin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Unraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitors.
Topics: Antiviral Agents; Crystallography, X-Ray; Drug Evaluation, Preclinical; Endonucleases; Enzyme Assays; Enzyme Inhibitors; Flavonoids; Influenza A virus; Microbial Sensitivity Tests; Molecular Structure; Protein Binding; Protein Domains; RNA-Dependent RNA Polymerase; Structure-Activity Relationship; Viral Proteins | 2020 |
Thrombin inhibitory activity of some polyphenolic compounds.
Topics: | 2014 |
Perioperative polyphenon E- and siliphos-inhibited colorectal tumor growth and metastases without impairment of gastric or abdominal wound healing in mouse models.
Topics: Abdomen; Analysis of Variance; Animals; Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Collagen; Colorectal Neoplasms; Drug Combinations; Female; Laparotomy; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasm Transplantation; Perioperative Period; Pneumoperitoneum, Artificial; Pressure; Random Allocation; Silybin; Silymarin; Stomach; Surgical Wound Dehiscence; Wound Healing | 2012 |
Alternative approaches to Hsp90 modulation for the treatment of cancer.
Topics: Animals; Antineoplastic Agents; Catechin; Drug Discovery; HSP90 Heat-Shock Proteins; Humans; Models, Molecular; Neoplasms; Novobiocin; Silybin; Silymarin | 2014 |
Assessment of the activity of directly acting antivirals and other products against different genotypes of hepatitis C virus prevalent in resource-poor countries.
Topics: Antiviral Agents; Catechin; Food Additives; Genotype; Hepacivirus; Hepatitis C; Humans; Nitro Compounds; Prevalence; Silybin; Silymarin; Thiazoles; Virus Replication | 2016 |
Anti‑proliferative activity of epigallocatechin‑3‑gallate and silibinin on soft tissue sarcoma cells.
Topics: Antineoplastic Agents; Antioxidants; Catechin; Cell Line, Tumor; Cell Proliferation; Fibrosarcoma; Humans; Liposarcoma; Sarcoma; Sarcoma, Synovial; Silybin; Silymarin | 2017 |
Skin Delivery of EGCG and Silibinin: Potential of Peptide Dendrimers for Enhanced Skin Permeation and Deposition.
Topics: Administration, Cutaneous; Animals; Antioxidants; Catechin; Dendrimers; Male; Peptides; Permeability; Rats; Rats, Wistar; Silybin; Silymarin; Skin Absorption | 2017 |
Revealing the Mechanism of EGCG, Genistein, Rutin, Quercetin, and Silibinin Against hIAPP Aggregation via Computational Simulations.
Topics: Catechin; Diabetes Mellitus, Type 2; Genistein; Humans; Islet Amyloid Polypeptide; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Quercetin; Rutin; Silybin | 2020 |
Silybin B and Cianidanol Inhibit M
Topics: Antiviral Agents; Catechin; COVID-19; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; SARS-CoV-2; Silybin; Spike Glycoprotein, Coronavirus | 2021 |